Altshuler Shaham LTD Exelixis, Inc. Transaction History

Altshuler Shaham LTD

$4.25 Billion
Q1 2025

A detailed history of Altshuler Shaham LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Altshuler Shaham LTD holds 99 shares of EXEL stock, worth $3,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 117 15.38%

Holding current value

$3,708

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$32.38 - $39.16 $582 - $704	-18 Reduced 15.38%	99 $3,000
Q4 2024 Feb 13, 2025	SELL	$25.39 - $36.46 $736 - $1,057	-29 Reduced 19.86%	117 $3,000
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $3,206 - $4,029	146 New	146 $3,000
Q4 2023 Feb 07, 2024	SELL	$19.25 - $24.13 $3,830 - $4,801	-199 Reduced 19.25%	835 $20,000
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $7,768 - $9,277	-408 Reduced 28.29%	1,034 $22,000
Q2 2023 Jul 24, 2023	BUY	$18.17 - $20.48 $26,201 - $29,532	1,442 New	1,442 $27,000
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $1,834 - $2,605	-117 Reduced 3.34%	3,385 $54,000
Q2 2022 Aug 10, 2022	SELL	$17.44 - $23.16 $11,859 - $15,748	-680 Reduced 16.26%	3,502 $73,000
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $71,219 - $94,805	4,182 New	4,182 $95,000
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $22,840 - $30,801	-1,242 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$20.67 - $26.94 $19,264 - $25,108	-932 Reduced 42.87%	1,242 $30,000
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $35,273 - $58,761	2,143 Added 6912.9%	2,174 $52,000
Q4 2019 Feb 11, 2020	SELL	$15.15 - $18.89 $469 - $585	-31 Reduced 50.0%	31 $1,000
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $7,690 - $9,852	-435 Reduced 87.53%	62 $1,000
Q2 2019 Aug 06, 2019	BUY	$18.93 - $24.75 $9,408 - $12,300	497 New	497 $11,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $853,090 - $1.08 Million	-43,525 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$13.65 - $21.8 $2,088 - $3,335	-153 Reduced 0.35%	43,525 $856,000
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $436,159 - $527,575	23,500 Added 116.46%	43,678 $940,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $24,852 - $35,780	-1,122 Reduced 5.27%	20,178 $447,000
Q4 2017 May 14, 2018	BUY	$24.23 - $30.93 $516,099 - $658,809	21,300	21,300 $648,000

Others Institutions Holding EXEL

# of Institutions

650

Shares Held

256M

Call Options Held

1.67M

Put Options Held

733K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Account

Altshuler Shaham LTD Exelixis, Inc. Transaction History